(Total Views: 560)
Posted On: 03/25/2025 7:54:08 AM
Post# of 154875
I know the company had a Plan B with their inflammation trial; I hope they get in gear pronto. From Dec newsletter:
Quote:
If the RECOVER-TLC team declines to include leronlimab, we will resume the pursuit of a pilot study in patients with ME/CFS, for which we already have a draft protocol synopsis and lead investigator identified.
(2)
(0)
